Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

163 results about "Polyhedral virus" patented technology

The polyhedral capsid from which the virus gets its name is an extremely stable protein crystal that protects the virus in the external environment. It dissolves in the alkaline midgut of moths and butterflies to release the virus particle and infect the larva.

Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof

ActiveCN101920012AGreat advantageProtein, high post-translational modification efficiencyViral antigen ingredientsVirus peptidesProtein targetTransfer vector
The invention provides a method for producing porcine circovirus type II capsid protein by utilizing a silkworm bioreactor, and belongs to the field of biotechnology. In the method, by taking a bombyx nuclear polyhedrosis virus as a vector, porcine circovirus type II capsid protein genes are integrated into a polyhedrosis promoter of the bombyx nuclear polyhedrosis virus so as to express target protein by a mode of the homologous recombination of a homologous arm of the nuclear polyhedrosis virus in a transfer vector and bombyx nuclear polyhedrosis virus (BmNPV) genes; a recombinant bombyx nuclear polyhedrosis virus containing target protein genes is obtained by a plaque sieving method, and the target protein is expressed in large scale by using a bombyx bioreactor so as to prepare a subunit vaccine containing recombinant porcine circovirus type II capsid protein; and piglet infection experiments verify that the subunit vaccine has the excellent immune protective effect. The method has the characteristics of high expression efficiency, good activity of the target protein, low production cost and the like, and is suitable for large-scale production.
Owner:PU LIKE BIO ENG +1

Method for select-breeding anti-virosis Bombyx mori varieties by utilizing Thailand Bombyx mori disease-resistant gene

The invention discloses a method for select-breeding anti-virosis Bombyx mori varieties by using Thailand Bombyx mori disease-resistant gene. The method comprises the steps of: selecting the present Bombyx mori varieties of 871 and 872 used both in spring and autumn in China as female parent and using the introduced Thailand tropical disease-resistant variety NL as male parent; respectively hybridizing and leading-in the disease-resistance gene; hybridizing second generation and third generation silkworm and respectively adopting mixed batches rearing for breeding; hybridizing each generation beginning from a second age and screening by adopting 'population feeding' NPV (nuclear polyhedrosis virus) and a method with the concentration of virus feeding 'increasing age by age in a gradient way'; taking the Bombyx mori varieties 871 and 872 as recurrent parent, respectively adopting reserve seed antivirus silkworm individual to backcross, using a method of the combination of 'backcrossing introduction' and 'generation directed virus feeding screening breeding' to obtain an NL pure and mild system with comparatively stable genetic character by a plurality of backcrosses and virus feeding screening. In the process of select-breeding, various economic characters and production properties of the system are consolidated and improved and the objects of pure breeds of 871NL and 872NL are bred. The obtained antivirus Bombyx mori variety has good economic characters, is sturdy and easy to keep.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Rabbit hemorrhagic disease virus recombinant subunit vaccine and preparation method thereof

The invention relates to a rabbit hemorrhagic disease virus recombinant subunit vaccine and a preparation method thereof. A vaccine production strain is a recombinant autographa californica nuclear polyhedrosis virus CGMCC No.8052 (China General Microbiological Culture Collection Center Number 8052), an expression vector adopted by the strain is a secretory expression vector and is provided with six histidine tags easy for protein detection and analysis; the strain is used as the production strain for producing the rabbit hemorrhagic disease virus recombinant subunit vaccine; the vaccine is free from viral genome, animal safety hazard and potential dispersity, is high in immunity pertinence, and can be used for exciting immunized animals to generate sufficient immune antibodies and long protective efficacy. RHDV-like (rabbit hemorrhagic disease virus-like) particles are produced according to the technology provided by the invention, the hemagglutination titer of virus liquid obtained from a 1000L bioreactor is (1 to 32768) to (1 to 262144), the protein expression quantity of the RHDV particles is about 150mg/L, 1L of semi-finished virus liquid can be prepared into 5,000-100,000 standard vaccines, and the preparation efficiency is higher than the domestic technical level by 8-20 times; the recombinant subunit vaccine is added with an adjuvant, so that the immune effect of the vaccine is improved; and the vaccine is a novel vaccine remarkably superior to an inactivated tissue vaccine produced in the prior art.
Owner:QILU ANIMAL HEALTH PROD

Method for using silkworm cultured cell to express antibacterial peptide Cecropin B

The invention discloses a method for using silkworm cultured cell to express antibacterial peptide Cecropin B. The method comprises the following steps: (1) using the total RNA extracted from the fat body cells of wild silkworm chrysalis as template, adopting RT-PCR amplification to obtain wild silkworm antibacterial peptide Cecropin B gene; using 1% agarose gel electrophoresis to perform PCR product analysis to the antibacterial peptide Cecropin B gene, using a PCR purification kit of Qiagene for purification, then cloning the purified PCR product to TA vector pCR2.1 to obtain pCR2.1-Cecropin B, utilizing the dideoxynucleotide chain termination to confirm the correctness of cloned gene order; using restriction endonuclease BamHI and HindIII to digest pCR2.1-Cecropin B and obtain Cecropin B genetic fragments, then cloning rhabdovirus transfer vector pBlueBacHisa in the genetic fragments to obtain reconstituted transfer vector; performing cotransfection of the reconstituted transfer vector and silkworm wild-type nuclear polyhedrosis virus BmNPV DNA in silkworm cultured cell, performing homologous recombination to generate recombinant virus; and (3) inoculating the recombinant virus containing wild silkworm antibacterial peptide Cecropin B gene in the silkworm cultured cell, infecting at 27 DEG C for three days to express the infection, and centrifuging to collect silkworm cultured cell.
Owner:ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products